Molecular modeling study of the opioid receptor interactions with series of cyclic deltorphin analogues

被引:0
作者
Slusarz, Magdalena J. [1 ]
机构
[1] Univ Gdansk, Fac Chem, PL-80952 Gdansk, Poland
关键词
deltorphin; dermorphin; opioid receptors; GPCR; receptor-ligand interaction; molecular modeling; WILD-TYPE; TRANSMEMBRANE DOMAIN; EXTRACELLULAR LOOP; CRYSTAL-STRUCTURE; BINDING POCKET; AMINO-ACIDS; MU; AGONIST; RESIDUES; LIGAND;
D O I
10.1002/psc.1371
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, ten tetra-and heptapeptide analogues of deltorphin containing the urea bridges between residues 2 and 4 have been docked into the delta- and mu-opioid receptors to explain their different biological activities. The important factors explaining particular ligand activity such as free energy of binding, conformation of the ligand, its location inside the binding pocket as well as the number and strength of the receptor-ligand interactions have been discussed. Several different binding modes for investigated ligands have been proposed. It appears that the binding site is not identical even for very similar ligands. Results of this study help to explain the differences in biological activity of the deltorphin analogues, their interaction with the opioid receptors at the molecular level and support designing a new generation of potent opioid drugs with improved selectivity. Copyright (C) 2011 European Peptide Society and John Wiley & Sons, Ltd.
引用
收藏
页码:554 / 564
页数:11
相关论文
共 53 条
  • [1] Ballesteros J. A., 1995, Neuroscience Methods, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471]
  • [2] Structural mimicry in G protein-coupled receptors: Implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors
    Ballesteros, JA
    Shi, L
    Javitch, JA
    [J]. MOLECULAR PHARMACOLOGY, 2001, 60 (01) : 1 - 19
  • [3] Role of aromatic transmembrane residues of the delta-opioid receptor in ligand recognition
    Befort, K
    Tabbara, L
    Kling, D
    Maigret, B
    Kieffer, BL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) : 10161 - 10168
  • [4] Constitutive activation of the δ opioid receptor by mutations in transmembrane domains III and VII
    Befort, K
    Zilliox, C
    Filliol, D
    Yue, SY
    Kieffer, BL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) : 18574 - 18581
  • [5] Befort K, 1996, MOL PHARMACOL, V49, P216
  • [6] Selectivity of μ-opioid receptor determined by interfacial residues near third extracellular loop
    Bonner, G
    Meng, F
    Akil, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 403 (1-2) : 37 - 44
  • [7] Bot G, 1998, J PHARMACOL EXP THER, V284, P283
  • [8] Case DA., 2008, AMBER 10 University of California
  • [9] Pharmacological profiles of selective non-peptidic δ opioid receptor ligands
    Chaturvedi, K
    Jiang, XJ
    Christoffers, KH
    Chinen, N
    Bandari, P
    Raveglia, LF
    Ronzoni, S
    Dondio, G
    Howells, RD
    [J]. MOLECULAR BRAIN RESEARCH, 2000, 80 (02): : 166 - 176
  • [10] μ opioid receptor:: role for the amino terminus as a determinant of ligand binding affinity
    Chaturvedi, K
    Shahrestanifar, M
    Howells, RD
    [J]. MOLECULAR BRAIN RESEARCH, 2000, 76 (01): : 64 - 72